None listed
Conditions
Interventions
None listed
Sponsors
Banaras Hindu University
Eligibility
Inclusion criteria
Inclusion criteria: FT (AGA) baby without any congenital/hereditary disorder. Mode of delivery: SVD or LSCS Absence of history of maternal/child systemic illness APGAR Score: 8/10 Parents/guardian of a child has given consent for the participation of their kids in the clinical trial for the study.
Exclusion criteria
Exclusion criteria: Parents/guardians of a child who has refused the participation of their kid in the clinical trial due to any reason. If the mother of the child had any systemic illness except skin disease during the antenatal period. Preterm, VLBW and ELBW babies Any associated disease or Congenital / hereditary disorders Thick meconium-stained liquor Meconium aspiration syndrome Severe birth asphyxia (APGAR score less than 8) The baby has complication during the treatment and dropped out from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Reduce the infection as well as increase the quality of life in terms of sterilization as well as significant role in skin microbiota of neonatesTimepoint: At 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| reduce the colony count of microbes in terms of antimicrobial effect of drugsTimepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactSubhabrata Sarkar
Dept of Kaumarbhritya-Balroga,IMS,BHU
Outcome results
None listed